FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005358181> ?p ?o ?g. }

• W2005358181 endingPage "1667" @default.
• W2005358181 startingPage "1654" @default.
• W2005358181 abstract "Massive transfusion (MT) is used for the treatment of uncontrolled hemorrhage. Earlier definitive control of life-threatening hemorrhage has significantly improved patient outcomes, but MT is still required. A number of recent advances in the area of MT have emerged, including the use of “hypotensive” or “delayed” resuscitation for victims of penetrating trauma before hemorrhage is controlled and “hemostatic resuscitation” with increased use of plasma and platelet transfusions in an attempt to maintain coagulation. These advances include the earlier use of hemostatic blood products (plasma, platelets, and cryoprecipitate), recombinant factor VIIa as an adjunct to the treatment of dilutional and consumptive coagulopathy, and a reduction in the use of isotonic crystalloid resuscitation. MT protocols have been developed to simplify and standardize transfusion practices. The authors of recent studies have advocated a 1:1:1 ratio of packed RBCs to fresh frozen plasma to platelet transfusions in patients requiring MT to avoid dilutional and consumptive coagulopathy and thrombocytopenia, and this has been associated with decreased mortality in recent reports from combat and civilian trauma. Earlier assessment of the exact nature of abnormalities in hemostasis has also been advocated to direct specific component and pharmacologic therapy to restore hemostasis, particularly in the determination of ongoing fibrinolysis. Massive transfusion (MT) is used for the treatment of uncontrolled hemorrhage. Earlier definitive control of life-threatening hemorrhage has significantly improved patient outcomes, but MT is still required. A number of recent advances in the area of MT have emerged, including the use of “hypotensive” or “delayed” resuscitation for victims of penetrating trauma before hemorrhage is controlled and “hemostatic resuscitation” with increased use of plasma and platelet transfusions in an attempt to maintain coagulation. These advances include the earlier use of hemostatic blood products (plasma, platelets, and cryoprecipitate), recombinant factor VIIa as an adjunct to the treatment of dilutional and consumptive coagulopathy, and a reduction in the use of isotonic crystalloid resuscitation. MT protocols have been developed to simplify and standardize transfusion practices. The authors of recent studies have advocated a 1:1:1 ratio of packed RBCs to fresh frozen plasma to platelet transfusions in patients requiring MT to avoid dilutional and consumptive coagulopathy and thrombocytopenia, and this has been associated with decreased mortality in recent reports from combat and civilian trauma. Earlier assessment of the exact nature of abnormalities in hemostasis has also been advocated to direct specific component and pharmacologic therapy to restore hemostasis, particularly in the determination of ongoing fibrinolysis." @default.
• W2005358181 created "2016-06-24" @default.
• W2005358181 creator A5025295131 @default.
• W2005358181 creator A5061848696 @default.
• W2005358181 date "2009-12-01" @default.
• W2005358181 modified "2023-10-17" @default.
• W2005358181 title "Massive Transfusion" @default.
• W2005358181 cites W1052023 @default.
• W2005358181 cites W1969097686 @default.
• W2005358181 cites W1971298489 @default.
• W2005358181 cites W1972351900 @default.
• W2005358181 cites W1975813860 @default.
• W2005358181 cites W1977331361 @default.
• W2005358181 cites W1979061819 @default.
• W2005358181 cites W1979769460 @default.
• W2005358181 cites W1981364809 @default.
• W2005358181 cites W1982692412 @default.
• W2005358181 cites W1983208351 @default.
• W2005358181 cites W1991642186 @default.
• W2005358181 cites W1991878197 @default.
• W2005358181 cites W1992252611 @default.
• W2005358181 cites W2000348294 @default.
• W2005358181 cites W2007551054 @default.
• W2005358181 cites W2009137628 @default.
• W2005358181 cites W2010277284 @default.
• W2005358181 cites W2010495983 @default.
• W2005358181 cites W2015068956 @default.
• W2005358181 cites W2015275652 @default.
• W2005358181 cites W2024327828 @default.
• W2005358181 cites W2024526916 @default.
• W2005358181 cites W2025117194 @default.
• W2005358181 cites W2025778465 @default.
• W2005358181 cites W2026535276 @default.
• W2005358181 cites W2030072120 @default.
• W2005358181 cites W2030322918 @default.
• W2005358181 cites W2036663989 @default.
• W2005358181 cites W2037234482 @default.
• W2005358181 cites W2038378391 @default.
• W2005358181 cites W2048912413 @default.
• W2005358181 cites W2049424448 @default.
• W2005358181 cites W2053122742 @default.
• W2005358181 cites W2056645952 @default.
• W2005358181 cites W2057251172 @default.
• W2005358181 cites W2057493194 @default.
• W2005358181 cites W2058563954 @default.
• W2005358181 cites W2058572688 @default.
• W2005358181 cites W2068854215 @default.
• W2005358181 cites W2069785744 @default.
• W2005358181 cites W2071688599 @default.
• W2005358181 cites W2075852148 @default.
• W2005358181 cites W2078658631 @default.
• W2005358181 cites W2080256233 @default.
• W2005358181 cites W2080870870 @default.
• W2005358181 cites W2082479261 @default.
• W2005358181 cites W2083005745 @default.
• W2005358181 cites W2084280207 @default.
• W2005358181 cites W2085024400 @default.
• W2005358181 cites W2086514018 @default.
• W2005358181 cites W2088395198 @default.
• W2005358181 cites W2089437714 @default.
• W2005358181 cites W2091129382 @default.
• W2005358181 cites W2091685079 @default.
• W2005358181 cites W2093200845 @default.
• W2005358181 cites W2094798901 @default.
• W2005358181 cites W2096984363 @default.
• W2005358181 cites W2108856858 @default.
• W2005358181 cites W2115579506 @default.
• W2005358181 cites W2124947475 @default.
• W2005358181 cites W2129551854 @default.
• W2005358181 cites W2142681490 @default.
• W2005358181 cites W2153851595 @default.
• W2005358181 cites W2162472063 @default.
• W2005358181 cites W2165111558 @default.
• W2005358181 cites W2165755420 @default.
• W2005358181 cites W2169337041 @default.
• W2005358181 cites W2169562700 @default.
• W2005358181 cites W2324829729 @default.
• W2005358181 cites W2340300883 @default.
• W2005358181 cites W4232706323 @default.
• W2005358181 cites W4238609292 @default.
• W2005358181 cites W4293915724 @default.
• W2005358181 cites W2323640683 @default.
• W2005358181 doi "https://doi.org/10.1378/chest.09-0251" @default.
• W2005358181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19995767" @default.
• W2005358181 hasPublicationYear "2009" @default.
• W2005358181 type Work @default.
• W2005358181 sameAs 2005358181 @default.
• W2005358181 citedByCount "100" @default.
• W2005358181 countsByYear W20053581812012 @default.
• W2005358181 countsByYear W20053581812013 @default.
• W2005358181 countsByYear W20053581812014 @default.
• W2005358181 countsByYear W20053581812015 @default.
• W2005358181 countsByYear W20053581812016 @default.
• W2005358181 countsByYear W20053581812017 @default.
• W2005358181 countsByYear W20053581812018 @default.
• W2005358181 countsByYear W20053581812019 @default.
• W2005358181 countsByYear W20053581812020 @default.
• W2005358181 countsByYear W20053581812021 @default.

• next